New Exploratory Alzheimer's Drug ANAVEX 2-73: Assessment of Safety and Cognitive Performance
- ANAVEX® Life Sciences Corp.
- Nov 27, 2015
- 1 min read
International Conference on Clinical Trials for Alzheimer’s Disease (CTAD) 2015, Barcelona, Spain
Steve Macfarlane, Paul Maruff, Marco Cecchi, Dennis Moore, Tasos Zografidis, Christopher Missling
